Literature DB >> 22401494

Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption.

Emmalee M Jones1, Manish Dubey, Phillip J Camp, Briana C Vernon, Jacek Biernat, Eckhard Mandelkow, Jaroslaw Majewski, Eva Y Chi.   

Abstract

The misfolding and aggregation of the intrinsically disordered, microtubule-associated tau protein into neurofibrillary tangles is implicated in the pathogenesis of Alzheimer's disease. However, the mechanisms of tau aggregation and toxicity remain unknown. Recent work has shown that anionic lipid membranes can induce tau aggregation and that membrane permeabilization may serve as a pathway by which protein aggregates exert toxicity, suggesting that the plasma membrane may play dual roles in tau pathology. This prompted our investigation to assess tau's propensity to interact with membranes and to elucidate the mutually disruptive structural perturbations the interactions induce in both tau and the membrane. We show that although highly charged and soluble, the full-length tau (hTau40) is also highly surface active, selectively inserts into anionic DMPG lipid monolayers and induces membrane morphological changes. To resolve molecular-scale structural details of hTau40 associated with lipid membranes, X-ray and neutron scattering techniques are utilized. X-ray reflectivity indicates hTau40s presence underneath a DMPG monolayer and penetration into the lipid headgroups and tailgroups, whereas grazing incidence X-ray diffraction shows that hTau40 insertion disrupts lipid packing. Moreover, both air/water and DMPG lipid membrane interfaces induce the disordered hTau40 to partially adopt a more compact conformation with density similar to that of a folded protein. Neutron reflectivity shows that tau completely disrupts supported DMPG bilayers while leaving the neutral DPPC bilayer intact. Our results show that hTau40s strong interaction with anionic lipids induces tau structural compaction and membrane disruption, suggesting possible membrane-based mechanisms of tau aggregation and toxicity in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401494      PMCID: PMC3319454          DOI: 10.1021/bi201857v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

Review 1.  Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

Authors:  D J Selkoe
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

3.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

4.  Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly.

Authors:  Eva Y Chi; Shelli L Frey; Amy Winans; Kin Lok H Lam; Kristian Kjaer; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

5.  Structural characterization of flexible proteins using small-angle X-ray scattering.

Authors:  Pau Bernadó; Efstratios Mylonas; Maxim V Petoukhov; Martin Blackledge; Dmitri I Svergun
Journal:  J Am Chem Soc       Date:  2007-04-06       Impact factor: 15.419

Review 6.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

7.  Structural memory of natively unfolded tau protein detected by small-angle X-ray scattering.

Authors:  Alexander V Shkumatov; Subashchandrabose Chinnathambi; Eckhard Mandelkow; Dmitri I Svergun
Journal:  Proteins       Date:  2011-05-10

8.  Membrane perturbation activity of cationic phenylene ethynylene oligomers and polymers: selectivity against model bacterial and mammalian membranes.

Authors:  Ying Wang; Yanli Tang; Zhijun Zhou; Eunkyung Ji; Gabriel P Lopez; Eva Y Chi; Kirk S Schanze; David G Whitten
Journal:  Langmuir       Date:  2010-08-03       Impact factor: 3.882

9.  Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Takeshi Kawarabayashi; Mikio Shoji; Linda H Younkin; Lin Wen-Lang; Dennis W Dickson; Tetsuro Murakami; Etsuro Matsubara; Koji Abe; Karen Hsiao Ashe; Steven G Younkin
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

10.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Authors:  Hilal A Lashuel; Benjamin M Petre; Joseph Wall; Martha Simon; Richard J Nowak; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

View more
  38 in total

1.  The fuzzy coat of pathological human Tau fibrils is a two-layered polyelectrolyte brush.

Authors:  Susanne Wegmann; Izhar D Medalsy; Eckhard Mandelkow; Daniel J Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

2.  Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.

Authors:  Elka R Georgieva; Shifeng Xiao; Peter P Borbat; Jack H Freed; David Eliezer
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

Review 3.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

4.  Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation.

Authors:  Patrick Barré; David Eliezer
Journal:  Protein Sci       Date:  2013-06-24       Impact factor: 6.725

5.  Interfacial Properties of NTAIL, an Intrinsically Disordered Protein.

Authors:  Anaïs Bénarouche; Johnny Habchi; Alain Cagna; Ofelia Maniti; Agnès Girard-Egrot; Jean-François Cavalier; Sonia Longhi; Frédéric Carrière
Journal:  Biophys J       Date:  2017-12-19       Impact factor: 4.033

Review 6.  Membrane interactions of intrinsically disordered proteins: The example of alpha-synuclein.

Authors:  Tapojyoti Das; David Eliezer
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-05-13       Impact factor: 3.036

Review 7.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 8.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 9.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

10.  Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes.

Authors:  Stefania A Mari; Susanne Wegmann; Katharina Tepper; Bradley T Hyman; Eva-Maria Mandelkow; Eckhard Mandelkow; Daniel J Müller
Journal:  Nano Lett       Date:  2018-04-17       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.